For the identification, assessment, and treatment of patients with cancer therapy

Details for Australian Patent Application No. 2007284724 (hide)

Owner Millennium Pharmaceuticals, Inc.

Inventors Bryant, Barbara M.; Mulligan, George; Damokosh, Andrew I.

Agent Davies Collison Cave

Pub. Number AU-A-2007284724

PCT Pub. Number WO2008/021183

Priority 60/836,764 10.08.06 US

Filing date 9 August 2007

Wipo publication date 21 February 2008

International Classifications

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/021183 Priority application(s): WO2008/021183

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007284733-Markers of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) and methods of use thereof

2007284715-Personal care product comprising collapsible water-containing capsules